MedTrace Logo

Multi-Treatment PNN Modulation for Chronic Rhinitis

NCT03791489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-07-24

Study results available
· View outcomes & findings →

Summary

Feasibility of treatment at multiple sites with the ClariFix cryoablation device for treatment of chronic rhinitis

Conditions

  • Chronic Rhinitis

Interventions

DEVICE

ClariFix

The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.

Sponsors & Collaborators

  • Arrinex, Inc.

    lead INDUSTRY

Principal Investigators

  • David Yen, MD · Specialty Physician Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-07-18
Completion
2019-07-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791489 on ClinicalTrials.gov